{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:12Z","timestamp":1789148952564,"version":"build-2803163510"},"reference-count":30,"publisher":"The Journal of Rheumatology","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to determine whether serum urate (SU)\u2013associated genetic variants differ in their influence on gout risk in people taking a diuretic compared to those not taking a diuretic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This research was conducted using the UK Biobank Resource (n = 359,876). Ten SU-associated single-nucleotide polymorphisms (SNP) were tested for their association with gout according to diuretic use. Gene-diuretic interactions for gout association were tested using a genetic risk score (GRS) and individual SNP by logistic regression adjusting for relevant confounders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>After adjustment, use of a loop diuretic was positively associated with prevalent gout (OR 2.34, 95% CI 2.08\u20132.63), but thiazide diuretics were inversely associated with prevalent gout (OR 0.60, 95% CI 0.55\u20130.66). Compared with a lower GRS (&lt; mean), a higher GRS (\u2265 mean) was positively associated with gout in those not taking diuretics (OR 2.63, 2.49\u20132.79), in those taking loop diuretics (OR 2.04, 95% CI 1.65\u20132.53), in those taking thiazide diuretics (OR 2.70, 2.26\u20133.23), and in those taking thiazide-like diuretics (OR 2.11, 95% CI 1.37\u20133.25). No nonadditive gene-diuretic interactions were observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In people taking diuretics, SU-associated genetic variants contribute strongly to gout risk, with a similar effect to that observed in those not taking a diuretic. These findings suggest that the contribution of genetic variants is not restricted to people with \u201cprimary\u201d gout, and that genetic variants can play an important role in gout susceptibility in the presence of other risk factors.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.191005","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T17:25:19Z","timestamp":1580577919000},"page":"1704-1711","source":"Crossref","is-referenced-by-count":7,"title":["Do Serum Urate\u2013associated Genetic Variants Influence Gout Risk in People Taking Diuretics? Analysis of the UK Biobank"],"prefix":"10.3899","volume":"47","author":[{"given":"Ravi K.","family":"Narang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Phipps-Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Topless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2299-4136","authenticated-orcid":false,"given":"Murray","family":"Cadzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Stamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony R.","family":"Merriman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"key":"2022062017050990000_47.11.1704.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203779"},{"key":"2022062017050990000_47.11.1704.2","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/key096","article-title":"Comorbidity clusters in people with gout: an observational cohort study with linked medical record review","volume":"57","author":"Bevis","year":"2018","journal-title":"Rheumatology"},{"key":"2022062017050990000_47.11.1704.3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.7326\/0003-4819-39-5-1062","article-title":"Primary and secondary gout","volume":"39","author":"Gutman","year":"1953","journal-title":"Ann Intern Med"},{"key":"2022062017050990000_47.11.1704.4","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2500"},{"key":"2022062017050990000_47.11.1704.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000504"},{"key":"2022062017050990000_47.11.1704.6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.109.934455"},{"key":"2022062017050990000_47.11.1704.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205877"},{"key":"2022062017050990000_47.11.1704.8","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.592"},{"key":"2022062017050990000_47.11.1704.9","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200311000-00002"},{"key":"2022062017050990000_47.11.1704.10","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000431740.32696.cc"},{"key":"2022062017050990000_47.11.1704.11","first-page":"1341","article-title":"Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study","volume":"33","author":"Hunter","year":"2006","journal-title":"J Rheumatol"},{"key":"2022062017050990000_47.11.1704.12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000496"},{"key":"2022062017050990000_47.11.1704.13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.040360"},{"key":"2022062017050990000_47.11.1704.14","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.semarthrit.2011.11.008","article-title":"Use of diuretics and the risk of gouty arthritis: a systematic review","volume":"41","author":"Hueskes","year":"2012","journal-title":"Semin Arthritis Rheu"},{"key":"2022062017050990000_47.11.1704.15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/art.38203","article-title":"Use of diuretics and risk of incident gout: a population-based case-control study","volume":"66","author":"Bruderer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2022062017050990000_47.11.1704.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.33315"},{"key":"2022062017050990000_47.11.1704.17","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2011.616564"},{"key":"2022062017050990000_47.11.1704.18","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/bjp.2008.343","article-title":"Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4","volume":"155","author":"El-Sheikh","year":"2008","journal-title":"Brit J Pharmacol"},{"key":"2022062017050990000_47.11.1704.19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006040415"},{"key":"2022062017050990000_47.11.1704.20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ki.1989.206","article-title":"Indirect coupling between sodium and urate transport in the proximal tubule","volume":"36","author":"Kahn","year":"1989","journal-title":"Kidney Int"},{"key":"2022062017050990000_47.11.1704.21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13075-017-1390-1","article-title":"Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank","volume":"19","author":"Cadzow","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2022062017050990000_47.11.1704.22","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/acr.22896","article-title":"Survey definitions of gout for epidemiologic studies: comparison with crystal identification as the gold standard","volume":"68","author":"Dalbeth","year":"2016","journal-title":"Arthrit Care Res"},{"key":"2022062017050990000_47.11.1704.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0579-z"},{"key":"2022062017050990000_47.11.1704.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201186"},{"key":"2022062017050990000_47.11.1704.25","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1931"},{"key":"2022062017050990000_47.11.1704.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61343-4"},{"key":"2022062017050990000_47.11.1704.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206534"},{"key":"2022062017050990000_47.11.1704.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d8190"},{"key":"2022062017050990000_47.11.1704.29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kex156","article-title":"The British Society for Rheumatology guideline for the management of gout","volume":"56","author":"Hui","year":"2017","journal-title":"Rheumatology"},{"key":"2022062017050990000_47.11.1704.30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209707"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.191005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:07:36Z","timestamp":1655770056000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.191005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,2]]},"published-print":{"date-parts":[[2020,11,1]]}},"alternative-id":["10.3899\/jrheum.191005"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.191005","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}